A Decade Later, Continued Transformation of Transcatheter Aortic Valve Replacement

Abstract

The emergence of transcatheter aortic valve replacement as an effective treatment option in appropriately selected patients with severe aortic valve stenosis has proven to be revolutionary to the fields of interventional cardiology and cardiac surgery. As percutaneous technologies continue to mature and indications for transcatheter valve therapy concurrently expand, the contemporary management of valvular heart disease necessitates a multidisciplinary heart team approach that considers the indication, multimodality imaging, anesthetic and procedural strategy, and selection of the appropriate valve prosthesis for each patient. We provide an overview of the historical development of transcatheter aortic valve replacement, commercially available and investigative devices, landmark clinical trial data, and developments on the horizon that aim to further advance the care of patients with aortic valve disease.

Mortality and resource utilization in surgical versus transcatheter repeat mitral valve replacement: A national analysis

“…To address this issue, newer TMVR technologies have been designed with smaller delivery apparatus while still accommodating for the large prostheses. The smallest apparatus being tested to date is measured at 20 French, close to the 14-French size observed in sheaths for transcatheter aortic valve replacement [ 40 , 41 ]. With evolving technologies available, improving protocols, and increasing familiarity with the transcatheter approach, TMVR is gaining acceptance as an alternative for high-risk repeat procedures [ 31 ].…”